The Centers for Disease Control and Prevention intends to award a sole-source, firm-fixed-price contract to OpenClinica LLC for a 1-year bridge contract to provide tuberculosis clinical trial management services. This is to ensure the continuation of a critical 10-year research portfolio, as OpenClinica uniquely designed the current tracking system and migrated all study data, making a vendor change impractical. The services involve essential clinical trial data intake, analysis, and monitoring required by FDA regulation. While this is a notice of intent and not a formal request for competitive quotes, the government will consider any responses received. Any quotation or response must be emailed to the specified contract specialist.